AI analysis of reddit posts finds underreported glp-1 drug symptoms

Penn researchers used AI to scan 400,000 Reddit posts from 70,000 GLP-1 users and found nearly 4% of those reporting side effects described menstrual irregularities, plus frequent chills and hot flashes.

Categorized in: AI News Science and Research
Published on: Sep 14, 2026
AI analysis of reddit posts finds underreported glp-1 drug symptoms

Researchers at the University of Pennsylvania used AI to analyze more than 400,000 Reddit posts from nearly 70,000 users taking GLP-1 drugs, identifying patient-reported symptoms that may be underrepresented in clinical trial data and official drug labels. The study, published in Nature Health, examined more than five years of conversations about semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound). Two categories emerged as signals worth further investigation: reproductive symptoms such as menstrual irregularities, and body temperature changes including chills and hot flashes.

The findings do not establish causation. Instead, they point to patterns in spontaneous patient reports that controlled research should examine more closely. "Some of the side effects we found, like nausea, are well known, and that shows that the method is picking up a real signal," said Sharath Chandra Guntuku, Research Associate Professor in Computer and Information Science at Penn Engineering and the study's senior author. "The underreported symptoms are leads that came from patients themselves, unprompted, and clinicians could potentially pay attention to them."

What Reddit posts reveal that trials may miss

Clinical trials are designed to establish efficacy and identify serious safety problems, but they cannot capture every symptom that emerges once millions of people start using a medication. Lyle Ungar, Professor in Computer and Information Science and a co-author, put it this way: "Clinical trials generally identify the most dangerous side effects of drugs. But they can fail to find what symptoms patients are most concerned about; even though social media is not necessarily representative, a large collection of posts may reflect additional concerns."

Roughly 44% of users in the study described at least one side effect. Gastrointestinal issues were the most common, consistent with the nausea and digestive problems already associated with these drugs. But other patterns stood out. Nearly 4% of users reporting side effects described reproductive symptoms, including bleeding between periods, heavy bleeding, and irregular cycles. Fatigue was the second most frequently reported complaint, despite relatively few clinical trials reporting it at levels that met established thresholds.

"We can't say that GLP-1s are actually causing these symptoms," said Neil Sehgal, the study's first author and a doctoral student in CIS. "But nearly 4% of the Reddit users in our sample reported menstrual irregularities, which would be even higher in a female-only sample. We think that's a signal worth investigating."

How AI makes computational social listening feasible

Patients rarely describe symptoms using standardized medical vocabulary. One person might say they feel unusually cold; another might mention constant chills. Researchers need a way to map that informal language onto structured categories such as those in the Medical Dictionary for Regulatory Activities (MedDRA). Before large language models, this required labor-intensive manual coding that limited the scale of analysis.

The approach, which Guntuku describes as "computational social listening," uses AI Data Analysis Courses techniques to identify patterns in large collections of online health conversations. Large language models such as GPT and Gemini now allow researchers to process and categorize vast amounts of text with consistent standardization. "Large language models have made it possible to do this kind of analysis much faster with a level of standardization that could be difficult to achieve before," Sehgal said.

The idea predates the current AI boom. In 2011, Ungar participated in one of the earliest efforts to mine internet user content for possible adverse drug effects. Since then, online patient communities have grown substantially. "Online patient communities work a lot like a neighborhood grapevine," Ungar said. "People who are living with these medications are swapping notes with each other in real time, sharing experiences that rarely make it into a doctor's office visit or an official report."

Why reproductive and temperature symptoms stand out

One biological explanation makes these patient reports particularly interesting. GLP-1 drugs are thought to work by engaging the hypothalamus, a brain region that helps regulate hunger, hormones, reproduction, and body temperature. Jena Shaw Tronieri, Senior Research Investigator at Penn's Center for Weight and Eating Disorders and a co-author, said this connection "could suggest that reports of menstrual changes and body temperature fluctuations are worth studying more systematically." She added that it does not mean the medications are causing the symptoms.

The researchers acknowledge that Reddit users do not represent the overall population of GLP-1 users. The platform skews younger, more male, and disproportionately American. Still, the fact that the method detected well-known side effects alongside novel ones suggests it is capturing genuine signals. The team wants to expand the analysis beyond Reddit and beyond English-language communities to test whether the patterns hold across different groups and platforms.

Why this matters for science and research professionals

This study demonstrates a practical application of AI for Science & Research: using large language models to convert unstructured text into standardized medical terminology at a scale that manual coding cannot match. For researchers working with patient-reported outcomes, pharmacovigilance data, or social media corpora, the method offers a template for identifying underreported signals quickly. The researchers are clear that online analysis is not a replacement for clinical trials, but it can move faster when a drug's adoption outpaces the research cycle. "The whole point of this kind of approach is that it can move quickly, and that's exactly when it's most valuable," Guntuku said.


Get Daily AI News

Your membership also unlocks:

700+ AI Courses
700+ Certifications
Personalized AI Learning Plan
6500+ AI Tools (no Ads)
Daily AI News by job industry (no Ads)